Cached score snapshot

US.SOLV · Solventum

110分制 57.4/110;5D動能v2 4/50;排序分 61.4/160

Ranking score 61.4/160
Main score 57.4/110
5D momentum v2 4/50
Rank #169
Setup grade F 26.4

Score breakdown

觀望

Medium twelvedata

Score and price trend

F 26.4 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 06-30 09-23 10-08 10-22 11-04 $72.21$90.67$109.13 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.398 · anchors 120 +1.07% -1.88% / +3.28% 62.5% 2.5% Actual +1.32% · vs median +0.25% · inside 25-75 band
30D observation +7.65% +3.47% / +12.91% 87.5% 0% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +0.76% -1.71% / +3.08% 58.1% 2.5% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-06-30 → 2026-11-04 · 235 archived points · 1 Improving turn signal · 8 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 61.4
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 57.4/110 (觀望)
5D momentum v2 4/50 (弱)
Score with momentum v2 61.4/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 89.895
ma50 86.7932
close 88.37
prevClose 88.75
avgVolume20 919821
volumeRatio 0.94
changePercent -0.43

Metrics snapshot

close 88.37
volume 860081
changePercent -0.43

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 57.4/110
Main rating 觀望
5D momentum v2 4/50
Score with momentum v2 61.4/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.4/5 · 一般

Dimension score 3.4/5
Dimension grade 一般

Sub-items

pbPoints 0.4
pePoints 0.5
epsPoints 0
roePoints 0.75
debtPoints 0.4
marginPoints 0.4
turnoverUsdM 76.0054
volumePoints 0.5
revenuePoints 0
dividendPoints 0
marketCapPoints 0.4

資金流 — 9.2/20 · 較差

Dimension score 9.2/20
Dimension grade 較差

Sub-items

cmfPoints 0.8
mfiPoints 1.6
obvPoints 4
vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.SOLV
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 10.2/15 · 一般

Dimension score 10.2/15
Dimension grade 一般

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 14.21

trend

score 4

details

qqq

ma20 718.2185
ma50 711.4152
name QQQ
close 741.21
points 2

spy

ma20 765.283
ma50 760.9058
name SPY
close 767.81
points 2
source twelvedata+fred
atrPct 2.3883
atrPoints 3
cciPoints 0.8
vixPoints 2.4
marketTrendPoints 4

催化劑 — 6/20 · 較差

Dimension score 6/20
Dimension grade 較差

Sub-items

catalyst

score 6

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 1
catalystPoints 6

風險管理 — 7.2/10 · 良好

Dimension score 7.2/10
Dimension grade 良好

Sub-items

position

score 1.4

details

atrPct 2.3883
turnoverUsdM 76.0054
liquidityPoints 0.4
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.SOLV
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 84.149

strength_details

ma_score 1.5
atr_score 2
rsi_score 2.5
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 1.1
stop_loss_percent 4.8
take_profit_price 92.8478
target_multiplier 1.9
technical_strength 1.68
take_profit_percent 5.1
positionPoints 1.4
stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 4.7765
diversificationPoints 2

技術信號 — 17.4/30 · 較差

Dimension score 17.4/30
Dimension grade 較差

Sub-items

bbPoints 2.4
adxPoints 3
sarPoints 1.2
vcpPoints 2.7
macdPoints 2.4

vcpPayload

vcp_pass false
vcp_score 2.7
vcp_reason 波幅收縮(13.5%→6%);跌縮量(近10日4日);站上MA50;升放量(近10日2日);Ready=Y;Confirm=N

vcp_metrics

up_days 3
vol_ref 978404.3667
down_days 5
vcp_ready true
above_ma50 true
avg_vol_10 981983.1
avg_vol_20 929216.55
avg_vol_30 978404.3667
range_pct_10 0.0604
range_pct_20 0.0863
range_pct_30 0.1348
up_expand_ok true
lookback_used 59
near_20d_high true
contraction_ok true
down_shrink_ok true
up_expand_days 2
breakout_20d_ok false
vol_ratio_10_30 1.0037
dist_to_20d_high 0.0615
down_shrink_days 4
breakout_level_20d 94.16
vcp_breakout_confirm false
contraction_ratio_10_30 0.4484
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.7
rsiKdjPoints 1.6
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0
shortMacdPoints 0.4
volConfirmPoints 0.6
volumePointsTechnical 0.8

情緒分析 — 4/10 · 較差

Dimension score 4/10
Dimension grade 較差

Sub-items

sentiment

score 4

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 3
sentimentScoreRaw 0.9

sentimentData

raw {"id":142357926,"url":"https://finnhub.io/api/news?id=fdca5f63b7d3d0ef3a66907f2d6ea673fdd6123a21fbd41d64b51e3dfc7c2860","image":"https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp","source":"ChartMill","related":"SOLV","summary":"SOLV stock: Solventum technical breakout setup with strong trend, tight consolidation, ChartMill ratings 8/10 and 9/10, defined entry/risk levels.","category":"company","datetime":1790167847,"headline":"Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds"}, {"id":142223244,"url":"https://finnhub.io/api/news?id=59633399520a47eacff7f99436994f965caf02cf678587f2923d18419da155f7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Earlier this quarter, Solventum reported results that surpassed analyst expectations, with both organic revenue and EPS beating estimates and management emphasizing strong execution and ongoing transformation efforts. An interesting angle is how Solventum’s exposure to surgical equipment and consumables, including AI and robotics-enabled solutions, supports relatively consistent procedural demand and innovation-driven opportunities. Now we’ll explore how this stronger-than-expected quarter,...","category":"company","datetime":1789625565,"headline":"What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders"}, {"id":142198487,"url":"https://finnhub.io/api/news?id=05a6bd6f2bd1d52654aa9e5f44225f78f2e05bf22c065fd021b67ffb8936e3c4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Solventum (NYSE:SOLV).","category":"company","datetime":1789577572,"headline":"Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses"}, {"id":142026578,"url":"https://finnhub.io/api/news?id=2931480ce1f7410699e9456064602e1ff2219f424fb1a9679dc6be5352820152","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"SOLV","summary":"Solventum Corporation (SOLV) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 10:15 AM EDTCompany ParticipantsBryan Hanson - CEO &...","category":"company","datetime":1788958625,"headline":"Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"}, {"id":141438444,"url":"https://finnhub.io/api/news?id=77e475d6daad55e35ae6daf27ae9ec6f3b1eaf004c16965e49f4c51a2f15d3c5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (SOLV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1788535819,"headline":"Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?"}, {"id":141379899,"url":"https://finnhub.io/api/news?id=cb518bc241fbc181265dbe9baa6adab575978b2b899e2700b505d6a6bba4958e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum's growth, higher earnings outlook and cost cuts strengthen its case, but heavy debt and 2027 margin risks temper the upside.","category":"company","datetime":1788375240,"headline":"Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?"}, {"id":141339718,"url":"https://finnhub.io/api/news?id=26071c76c25a1bdffce7a09020cca095f0cfc5a5dbc5292e3e031d35f82698d9","image":"","source":"Fintel","related":"SOLV","summary":"","category":"company","datetime":1787947900,"headline":"Solventum (SOLV) Price Target Increased by 10.88% to 95.90"}, {"id":141365587,"url":"https://finnhub.io/api/news?id=68ec63ea3407f00b7c5c4073a7a1c3cac4476c335afebb635ba07c026deeacd4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.","category":"company","datetime":1787938372,"headline":"3 Reasons to Avoid SOLV and 1 Stock to Buy Instead"}
raw_source {"id":142357926,"url":"https://finnhub.io/api/news?id=fdca5f63b7d3d0ef3a66907f2d6ea673fdd6123a21fbd41d64b51e3dfc7c2860","image":"https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp","source":"ChartMill","related":"SOLV","summary":"SOLV stock: Solventum technical breakout setup with strong trend, tight consolidation, ChartMill ratings 8/10 and 9/10, defined entry/risk levels.","category":"company","datetime":1790167847,"headline":"Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds"}, {"id":142252751,"url":"https://finnhub.io/api/news?id=8dffac6f353cafa877be7a43649e86347a4a64618a16a41f9143e33d6c293069","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304057123/image_1304057123.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"SOLV","summary":"Solventum trades at a significant discount to medical technology peers, with a forward P/E of ~13x and suppressed EV/EBITDA multiples. Learn more about SOLV stock here.","category":"company","datetime":1789717319,"headline":"Solventum: Divestiture Unlocking Upside In A Spinoff Revaluation Play"}, {"id":142231517,"url":"https://finnhub.io/api/news?id=d2fbcf5a6ad084f6029a82395e4b80e290f082b45503961eff049d8b5a9b6b6c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.","category":"company","datetime":1789660260,"headline":"Here's Why You Should Hold Solventum Stock in Your Portfolio for Now"}, {"id":142223244,"url":"https://finnhub.io/api/news?id=59633399520a47eacff7f99436994f965caf02cf678587f2923d18419da155f7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Earlier this quarter, Solventum reported results that surpassed analyst expectations, with both organic revenue and EPS beating estimates and management emphasizing strong execution and ongoing transformation efforts. An interesting angle is how Solventum’s exposure to surgical equipment and consumables, including AI and robotics-enabled solutions, supports relatively consistent procedural demand and innovation-driven opportunities. Now we’ll explore how this stronger-than-expected quarter,...","category":"company","datetime":1789625565,"headline":"What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders"}, {"id":142198487,"url":"https://finnhub.io/api/news?id=05a6bd6f2bd1d52654aa9e5f44225f78f2e05bf22c065fd021b67ffb8936e3c4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Solventum (NYSE:SOLV).","category":"company","datetime":1789577572,"headline":"Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses"}, {"id":142138123,"url":"https://finnhub.io/api/news?id=996fef6f894db5de5b3f7384dca6b49a263730212beb8addd07e9b0e2bdef5ff","image":"","source":"Benzinga","related":"SOLV","summary":"BTIG analyst Ryan Zimmerman reiterates Solventum (NYSE:SOLV) with a Buy and maintains $95 price target.","category":"company","datetime":1789367355,"headline":"BTIG Reiterates Buy on Solventum, Maintains $95 Price Target"}, {"id":142025907,"url":"https://finnhub.io/api/news?id=907ee1885f7be1df8b9cc9496a9dd6e035c78965016b6901e42093328482cfc9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.","category":"company","datetime":1788966878,"headline":"3 S&P 500 Stocks with Open Questions"}, {"id":142026578,"url":"https://finnhub.io/api/news?id=2931480ce1f7410699e9456064602e1ff2219f424fb1a9679dc6be5352820152","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"SOLV","summary":"Solventum Corporation (SOLV) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 10:15 AM EDTCompany ParticipantsBryan Hanson - CEO &...","category":"company","datetime":1788958625,"headline":"Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"}, {"id":141438444,"url":"https://finnhub.io/api/news?id=77e475d6daad55e35ae6daf27ae9ec6f3b1eaf004c16965e49f4c51a2f15d3c5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (SOLV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1788535819,"headline":"Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?"}, {"id":141389683,"url":"https://finnhub.io/api/news?id=8bcc4d32667b76be3a5f2396ca65a345fbe62348b68063d767e0d78ef2844e12","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, Sept. 9, 2026, beginning at approximately 10:15 a.m. EDT in Boston, MA.","category":"company","datetime":1788379500,"headline":"Solventum to Participate in the 2026 Wells Fargo Healthcare Conference"}, {"id":141379899,"url":"https://finnhub.io/api/news?id=cb518bc241fbc181265dbe9baa6adab575978b2b899e2700b505d6a6bba4958e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum's growth, higher earnings outlook and cost cuts strengthen its case, but heavy debt and 2027 margin risks temper the upside.","category":"company","datetime":1788375240,"headline":"Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?"}, {"id":141339718,"url":"https://finnhub.io/api/news?id=26071c76c25a1bdffce7a09020cca095f0cfc5a5dbc5292e3e031d35f82698d9","image":"","source":"Fintel","related":"SOLV","summary":"","category":"company","datetime":1787947900,"headline":"Solventum (SOLV) Price Target Increased by 10.88% to 95.90"}, {"id":141365587,"url":"https://finnhub.io/api/news?id=68ec63ea3407f00b7c5c4073a7a1c3cac4476c335afebb635ba07c026deeacd4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.","category":"company","datetime":1787938372,"headline":"3 Reasons to Avoid SOLV and 1 Stock to Buy Instead"}, {"id":141365430,"url":"https://finnhub.io/api/news?id=61a03b449d5a885e39b6dbcae3a9e72871ea186a8e8c5a222ce1430ced2b10dc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.","category":"company","datetime":1787923492,"headline":"3 Value Stocks with Open Questions"}, {"id":141314075,"url":"https://finnhub.io/api/news?id=cffee9de1f9c3c33dbc7f50b1cfc92908d0a7791b14fc63ba2cec5a04d3d6cb8","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1285071364/image_1285071364.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"SOLV","summary":"Embecta (EMBC) looks like a deep value buy: P/E under 3x, 50%+ FCF yield, insider buying and rebound setup.","category":"company","datetime":1787613074,"headline":"The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 3
recomputed_at_score true
sentiment_score_raw 0.9
source_article_count 15
discarded_article_count 7
sentimentPoints 4

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.4 5/110 68% 3.4
資金流 9.2 20/110 46% 9.2
市場環境 10.2 15/110 68% 10.2
催化劑 6 20/110 30% 6
風險管理 7.2 10/110 72% 7.2
技術信號 17.4 30/110 58% 17.4
情緒分析 4 10/110 40% 4

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 4/50
ret_5d -0.0052
max_score 50
max_total 50
raw_total 4
vcp_bonus 0
vol_ratio 0.9256
ret_points 0
vol_points 0
range_ratio 0.8673
volat_points 0
day_range_pct 0.0194
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 4
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.4

details

atrPct 2.3883
turnoverUsdM 76.0054
liquidityPoints 0.4
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.SOLV
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 84.149

strength_details

ma_score 1.5
atr_score 2
rsi_score 2.5
macd_score 1.5
volume_score 1
market_adjustment 1
risk_reward_ratio 1.1
stop_loss_percent 4.8
take_profit_price 92.8478
target_multiplier 1.9
technical_strength 1.68
take_profit_percent 5.1
positionPoints 1.4
stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 4.7765
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.4/5分
資金流分析總分: 9.2/20分
市場環境分析總分: 10.2/15分
催化劑分析: 6/20分
風險管理總分: 7.2/10分
技術信號分析總分: 17.4/30分
情緒分析: 4/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 85.71
atr
atr 2.1105
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.39
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value -76.78
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.1937
kdj
d 35.23
j 39.58
k 36.68
rule Cursor_18.24 K/D cross
score 4
signal 金叉
mfi
rule Cursor_18.24 MFI bands
level 弱流入
score 4
value 43.05
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 10
trend 強流入
value 212888
recentSlope -10521.2
previousSlope -363180
rsi
value 35.82
sar
rule Cursor_18.24 Parabolic SAR
score 4
trend 下降
value 90.7066
position SAR喺價上
distancePct 2.64
previousTrend 下降
ma50
value 86.7932
macd
macd 0.344
trend 中性偏多
signal 0.7916
histogram -0.4476
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 2
value 89.9574
position <VWAP
consecutiveAbove 0
volume
rule Cursor_18.24 volume ratio
level 無力
ratio 0.94
score 4
avgVolume 919821
currentVolume 860081
derived
ma20 89.895
ma50 86.7932
prevClose 88.75
avgVolume10 987641
avgVolume20 919821
changePercent -0.43
avgVolumeForScore 919821
ma_cross
ma20 89.895
ma50 86.7932
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 90.057
prevMa50 86.5514
spreadPct 3.57
isVolumeBreakout false
bollinger
lower 86.8903
upper 92.8997
position 中間
rsi_short
value 30.39
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 0.94

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.3882539323299765,
        "turnoverUsdM": 76.00535797,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.SOLV",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 84.149,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 2.5,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 4.8,
      "take_profit_price": 92.8478,
      "target_multiplier": 1.9,
      "technical_strength": 1.68,
      "take_profit_percent": 5.1
    },
    "positionPoints": 1.4,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.776507864659953,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 61.4,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 57.4,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 4
  },
  "market": {
    "ma20": 89.895,
    "ma50": 86.7932,
    "close": 88.37,
    "prevClose": 88.75,
    "avgVolume20": 919821,
    "volumeRatio": 0.94,
    "changePercent": -0.43
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 4,
    "details": {
      "ret_5d": -0.005178430710345516,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 4,
      "vcp_bonus": 0,
      "vol_ratio": 0.9255980212578004,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.8672618282549849,
      "volat_points": 0,
      "day_range_pct": 0.019350458300328093,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 4,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 61.4,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.4,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 68,
        "contribution": 3.4
      },
      {
        "raw": 9.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 46,
        "contribution": 9.2
      },
      {
        "raw": 10.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 68,
        "contribution": 10.2
      },
      {
        "raw": 6,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 7.2,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 72,
        "contribution": 7.2
      },
      {
        "raw": 17.4,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 58,
        "contribution": 17.4
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 57.4,
    "details": [
      "基本面分析總分: 3.4/5分",
      "資金流分析總分: 9.2/20分",
      "市場環境分析總分: 10.2/15分",
      "催化劑分析: 6/20分",
      "風險管理總分: 7.2/10分",
      "技術信號分析總分: 17.4/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 6,
      "基本面": 3.4,
      "資金流": 9.2,
      "市場環境": 10.2,
      "情緒分析": 4,
      "技術信號": 17.4,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 1
            }
          },
          "catalystPoints": 6
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.5,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.4,
          "marginPoints": 0.4,
          "turnoverUsdM": 76.00535797,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 1.6,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.SOLV",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 14.21
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 718.2184960000001,
                "ma50": 711.4151976999997,
                "name": "QQQ",
                "close": 741.21002,
                "points": 2
              },
              "spy": {
                "ma20": 765.28299795,
                "ma50": 760.9057979799998,
                "name": "SPY",
                "close": 767.81,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.3882539323299765,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142357926,
                "url": "https://finnhub.io/api/news?id=fdca5f63b7d3d0ef3a66907f2d6ea673fdd6123a21fbd41d64b51e3dfc7c2860",
                "image": "https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp",
                "source": "ChartMill",
                "related": "SOLV",
                "summary": "SOLV stock: Solventum technical breakout setup with strong trend, tight consolidation, ChartMill ratings 8/10 and 9/10, defined entry/risk levels.",
                "category": "company",
                "datetime": 1790167847,
                "headline": "Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds"
              },
              {
                "id": 142223244,
                "url": "https://finnhub.io/api/news?id=59633399520a47eacff7f99436994f965caf02cf678587f2923d18419da155f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Earlier this quarter, Solventum reported results that surpassed analyst expectations, with both organic revenue and EPS beating estimates and management emphasizing strong execution and ongoing transformation efforts. An interesting angle is how Solventum’s exposure to surgical equipment and consumables, including AI and robotics-enabled solutions, supports relatively consistent procedural demand and innovation-driven opportunities. Now we’ll explore how this stronger-than-expected quarter,...",
                "category": "company",
                "datetime": 1789625565,
                "headline": "What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders"
              },
              {
                "id": 142198487,
                "url": "https://finnhub.io/api/news?id=05a6bd6f2bd1d52654aa9e5f44225f78f2e05bf22c065fd021b67ffb8936e3c4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Solventum (NYSE:SOLV).",
                "category": "company",
                "datetime": 1789577572,
                "headline": "Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses"
              },
              {
                "id": 142026578,
                "url": "https://finnhub.io/api/news?id=2931480ce1f7410699e9456064602e1ff2219f424fb1a9679dc6be5352820152",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "Solventum Corporation (SOLV) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 10:15 AM EDTCompany ParticipantsBryan Hanson - CEO &...",
                "category": "company",
                "datetime": 1788958625,
                "headline": "Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141438444,
                "url": "https://finnhub.io/api/news?id=77e475d6daad55e35ae6daf27ae9ec6f3b1eaf004c16965e49f4c51a2f15d3c5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (SOLV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1788535819,
                "headline": "Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 141379899,
                "url": "https://finnhub.io/api/news?id=cb518bc241fbc181265dbe9baa6adab575978b2b899e2700b505d6a6bba4958e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum's growth, higher earnings outlook and cost cuts strengthen its case, but heavy debt and 2027 margin risks temper the upside.",
                "category": "company",
                "datetime": 1788375240,
                "headline": "Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?"
              },
              {
                "id": 141339718,
                "url": "https://finnhub.io/api/news?id=26071c76c25a1bdffce7a09020cca095f0cfc5a5dbc5292e3e031d35f82698d9",
                "image": "",
                "source": "Fintel",
                "related": "SOLV",
                "summary": "",
                "category": "company",
                "datetime": 1787947900,
                "headline": "Solventum (SOLV) Price Target Increased by 10.88% to 95.90"
              },
              {
                "id": 141365587,
                "url": "https://finnhub.io/api/news?id=68ec63ea3407f00b7c5c4073a7a1c3cac4476c335afebb635ba07c026deeacd4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1787938372,
                "headline": "3 Reasons to Avoid SOLV and 1 Stock to Buy Instead"
              }
            ],
            "raw_source": [
              {
                "id": 142357926,
                "url": "https://finnhub.io/api/news?id=fdca5f63b7d3d0ef3a66907f2d6ea673fdd6123a21fbd41d64b51e3dfc7c2860",
                "image": "https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp",
                "source": "ChartMill",
                "related": "SOLV",
                "summary": "SOLV stock: Solventum technical breakout setup with strong trend, tight consolidation, ChartMill ratings 8/10 and 9/10, defined entry/risk levels.",
                "category": "company",
                "datetime": 1790167847,
                "headline": "Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds"
              },
              {
                "id": 142252751,
                "url": "https://finnhub.io/api/news?id=8dffac6f353cafa877be7a43649e86347a4a64618a16a41f9143e33d6c293069",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304057123/image_1304057123.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "Solventum trades at a significant discount to medical technology peers, with a forward P/E of ~13x and suppressed EV/EBITDA multiples. Learn more about SOLV stock here.",
                "category": "company",
                "datetime": 1789717319,
                "headline": "Solventum: Divestiture Unlocking Upside In A Spinoff Revaluation Play"
              },
              {
                "id": 142231517,
                "url": "https://finnhub.io/api/news?id=d2fbcf5a6ad084f6029a82395e4b80e290f082b45503961eff049d8b5a9b6b6c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.",
                "category": "company",
                "datetime": 1789660260,
                "headline": "Here's Why You Should Hold Solventum Stock in Your Portfolio for Now"
              },
              {
                "id": 142223244,
                "url": "https://finnhub.io/api/news?id=59633399520a47eacff7f99436994f965caf02cf678587f2923d18419da155f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Earlier this quarter, Solventum reported results that surpassed analyst expectations, with both organic revenue and EPS beating estimates and management emphasizing strong execution and ongoing transformation efforts. An interesting angle is how Solventum’s exposure to surgical equipment and consumables, including AI and robotics-enabled solutions, supports relatively consistent procedural demand and innovation-driven opportunities. Now we’ll explore how this stronger-than-expected quarter,...",
                "category": "company",
                "datetime": 1789625565,
                "headline": "What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders"
              },
              {
                "id": 142198487,
                "url": "https://finnhub.io/api/news?id=05a6bd6f2bd1d52654aa9e5f44225f78f2e05bf22c065fd021b67ffb8936e3c4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Solventum (NYSE:SOLV).",
                "category": "company",
                "datetime": 1789577572,
                "headline": "Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses"
              },
              {
                "id": 142138123,
                "url": "https://finnhub.io/api/news?id=996fef6f894db5de5b3f7384dca6b49a263730212beb8addd07e9b0e2bdef5ff",
                "image": "",
                "source": "Benzinga",
                "related": "SOLV",
                "summary": "BTIG  analyst Ryan Zimmerman   reiterates Solventum (NYSE:SOLV) with a Buy and maintains $95 price target.",
                "category": "company",
                "datetime": 1789367355,
                "headline": "BTIG Reiterates Buy on Solventum, Maintains $95 Price Target"
              },
              {
                "id": 142025907,
                "url": "https://finnhub.io/api/news?id=907ee1885f7be1df8b9cc9496a9dd6e035c78965016b6901e42093328482cfc9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
                "category": "company",
                "datetime": 1788966878,
                "headline": "3 S&P 500 Stocks with Open Questions"
              },
              {
                "id": 142026578,
                "url": "https://finnhub.io/api/news?id=2931480ce1f7410699e9456064602e1ff2219f424fb1a9679dc6be5352820152",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "Solventum Corporation (SOLV) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 10:15 AM EDTCompany ParticipantsBryan Hanson - CEO &...",
                "category": "company",
                "datetime": 1788958625,
                "headline": "Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141438444,
                "url": "https://finnhub.io/api/news?id=77e475d6daad55e35ae6daf27ae9ec6f3b1eaf004c16965e49f4c51a2f15d3c5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (SOLV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1788535819,
                "headline": "Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 141389683,
                "url": "https://finnhub.io/api/news?id=8bcc4d32667b76be3a5f2396ca65a345fbe62348b68063d767e0d78ef2844e12",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, Sept. 9, 2026, beginning at approximately 10:15 a.m. EDT in Boston, MA.",
                "category": "company",
                "datetime": 1788379500,
                "headline": "Solventum to Participate in the 2026 Wells Fargo Healthcare Conference"
              },
              {
                "id": 141379899,
                "url": "https://finnhub.io/api/news?id=cb518bc241fbc181265dbe9baa6adab575978b2b899e2700b505d6a6bba4958e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum's growth, higher earnings outlook and cost cuts strengthen its case, but heavy debt and 2027 margin risks temper the upside.",
                "category": "company",
                "datetime": 1788375240,
                "headline": "Should Investors Buy SOLV as Growth Improves but Debt Risks Persist?"
              },
              {
                "id": 141339718,
                "url": "https://finnhub.io/api/news?id=26071c76c25a1bdffce7a09020cca095f0cfc5a5dbc5292e3e031d35f82698d9",
                "image": "",
                "source": "Fintel",
                "related": "SOLV",
                "summary": "",
                "category": "company",
                "datetime": 1787947900,
                "headline": "Solventum (SOLV) Price Target Increased by 10.88% to 95.90"
              },
              {
                "id": 141365587,
                "url": "https://finnhub.io/api/news?id=68ec63ea3407f00b7c5c4073a7a1c3cac4476c335afebb635ba07c026deeacd4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1787938372,
                "headline": "3 Reasons to Avoid SOLV and 1 Stock to Buy Instead"
              },
              {
                "id": 141365430,
                "url": "https://finnhub.io/api/news?id=61a03b449d5a885e39b6dbcae3a9e72871ea186a8e8c5a222ce1430ced2b10dc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.",
                "category": "company",
                "datetime": 1787923492,
                "headline": "3 Value Stocks with Open Questions"
              },
              {
                "id": 141314075,
                "url": "https://finnhub.io/api/news?id=cffee9de1f9c3c33dbc7f50b1cfc92908d0a7791b14fc63ba2cec5a04d3d6cb8",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1285071364/image_1285071364.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "Embecta (EMBC) looks like a deep value buy: P/E under 3x, 50%+ FCF yield, insider buying and rebound setup.",
                "category": "company",
                "datetime": 1787613074,
                "headline": "The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 15,
            "discarded_article_count": 7
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.4,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 2.7,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.7,
            "vcp_reason": "波幅收縮(13.5%→6%);跌縮量(近10日4日);站上MA50;升放量(近10日2日);Ready=Y;Confirm=N",
            "vcp_metrics": {
              "up_days": 3,
              "vol_ref": 978404.3666666667,
              "down_days": 5,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 981983.1,
              "avg_vol_20": 929216.55,
              "avg_vol_30": 978404.3666666667,
              "range_pct_10": 0.06042774697295466,
              "range_pct_20": 0.08634151861491451,
              "range_pct_30": 0.1347742446531628,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.003657724204079,
              "dist_to_20d_high": 0.061491079014443416,
              "down_shrink_days": 4,
              "breakout_level_20d": 94.16,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.4483627204030231
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 1.6,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.3882539323299765,
              "turnoverUsdM": 76.00535797,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.SOLV",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 84.149,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 2.5,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 4.8,
            "take_profit_price": 92.8478,
            "target_multiplier": 1.9,
            "technical_strength": 1.68,
            "take_profit_percent": 5.1
          },
          "positionPoints": 1.4,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.776507864659953,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 2.1105,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.39
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -76.78
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1937
    },
    "kdj": {
      "d": 35.23,
      "j": 39.58,
      "k": 36.68,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 43.05
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 212888,
      "recentSlope": -10521.2,
      "previousSlope": -363180
    },
    "rsi": 35.82,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 90.7066,
      "position": "SAR喺價上",
      "distancePct": 2.64,
      "previousTrend": "下降"
    },
    "ma50": 86.7932,
    "macd": {
      "macd": 0.3439818223713047,
      "trend": "中性偏多",
      "signal": 0.7915985740611797,
      "histogram": -0.447616751689875
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 89.9574,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.94,
      "score": 4,
      "avgVolume": 919821,
      "currentVolume": 860081
    },
    "derived": {
      "ma20": 89.895,
      "ma50": 86.7932,
      "prevClose": 88.75,
      "avgVolume10": 987641,
      "avgVolume20": 919821,
      "changePercent": -0.43,
      "avgVolumeForScore": 919821
    },
    "ma_cross": {
      "ma20": 89.895,
      "ma50": 86.7932,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 90.057,
      "prevMa50": 86.5514,
      "spreadPct": 3.57,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 86.8903,
      "upper": 92.8997,
      "position": "中間"
    },
    "rsi_short": 30.39,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.94
    }
  }
}

Raw metrics JSON

{
  "close": 88.37,
  "volume": 860081,
  "changePercent": -0.43
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.